EYE DISEASE TREATMENT News, Sports, Shopping, Travel information

Looking for Eye Disease Treatment?
Find it NOW on NeXplore.com! The New Web 2.0 Search Engine!
www.nexplore.com

Thrombogenics Begins Phase Iii Program With Microplasmin For The Non-surgical Treatment Of Back Of The Eye Disease
leuven, belgium, january 9 /prnewswire/ -- - thrombogenics' lead product to be studied in the treatment of vitreomacular adhesion in the us and europe thrombogenics nv (euronext brussels: thr), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, announces today that it has started the phase iii clinical program of microplasmin for the ...
www.itnews.it

Thrombogenics Begins Phase Iii Program With Microplasmin For The Non-surgical Treatment Of Back Of The Eye Disease
thrombogenics nv , a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, announces today that it has started the phase iii clinical program of microplasmin for the non-surgical treatment of back of the eye disease, the final step in the clinical development of this potential new therapy.
biz.yahoo.com

Thrombogenics Begins Phase Iii Program With Microplasmin For The Non-surgical Treatment Of Back Of The Eye Disease
-
biz.yahoo.com

My Pharmiweb.com
leuven, belgium – january 9, 2009 - thrombogenics nv (euronext brussels: thr), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, announces today that it has started the phase iii clinical program of microplasmin for the non-surgical treatment of back of the eye disease, the final step in the clinical development of this potential new therapy.
www.pharmiweb.com

Discovery Of Gene That Increases Susceptibility To Crohn's Disease
researchers at mcgill university, the research institute of the mcgill university health centre (ri muhc) and the mcgill university and gã©nome quã©bec innovation centre, along with colleagues at other canadian and belgian institutions, have discovered dna variations in a gene that increases susceptibility to developing crohn's disease.
www.medicalnewstoday.com

Gene That Increases Susceptibility To Crohn's Disease Discovered
researchers have discovered dna variations in a gene that increases susceptibility to developing crohn's disease. a 'broken' bacterial sensor doesn’t detect harmful bacteria in the digestive system.
www.sciencedaily.com

Mcgill Researchers Discover Gene That Increases Susceptibility To Crohn's Disease
( mcgill university ) researchers at mcgill university, the research institute of the mcgill university health center and the mcgill university and génome québec innovation center, along with colleagues at other canadian and belgian institutions, have discovered dna variations in a gene that increases susceptibility to developing crohn's disease. their study was published in the january issue of ...
www.eurekalert.org

Cytomegalovirus: Cell Death May Bring New Life To Treatment Of Retinal Disease
just days after the first retinal cell gets infected with the common cytomegalovirus, contiguous cells start committing suicide and researchers believe their death may provide clues to better treatment of this potentially blinding infection.
www.medicalnewstoday.com

Researchers Discover Gene That Increases Susceptibility To Crohn's Disease
researchers at mcgill university, the research institute of the mcgill university health centre (ri muhc) and the mcgill university and génome québec innovation centre, along with colleagues at other canadian and belgian institutions, have discovered dna variations in a gene that increases susceptibility to developing crohn's disease. their study was published in the january issue of the journal ...
www.physorg.com

Illinois, 41 Other States In Salmonella Outbreak
a nationwide salmonella outbreak that has struck 42 states has put about one in five of its victims in the hospital, the u.s. centers for disease control and prevention said thursday.
news.yahoo.com

Thrombogenics Begins Phase Iii Program With Microplasmin For The Non ... - Phramalive.com
- thrombogenics' lead product to be studied in the treatment of vitreomacular adhesion in the us and europe thrombogenics nv , a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, announces today that ...
www.pharmalive.com

Esbatech's Antibody Fragment Enters Phase I/iia Clinical Development ... - Phramalive.com
zurich, switzerland, january 09, 2009/prnewswire/ -- esbatech ag, a leading developer of antibody fragment therapeutics, today announced the initiation of the phase i/iia clinical development of its anti-tnf alpha antibody fragment esba105 in ...
www.pharmalive.com

Update 1-thrombogenics Eye Drug Enters Final Research Phase - Reuters
brussels, jan 9 (reuters) - belgian biotech company thrombogenics ( thr.br ) said on friday that it had entered the third phase of trials on microplasmin, a non-surgical treatment for a disease that affects the back of the eye. these trials are the ...
www.reuters.com

Novabay Issued Key Composition Of Matter Patent For Aganocide ... - Genetic Engineering News
novabay pharmaceuticals, inc. ( amex: nby , www.novabaypharma.com ) reports that the united states patent and trademark office has approved the issuance of u.s. patent no. 7,462,361 to novabay for novel aganocide compounds including its current lead ...
www.genengnews.com

Still No Known Source Of Salmonella Outbreak That May Have Killed 1 - Fox News
atlanta — a nationwide salmonella outbreak that has struck 42 states has put about one in five of its victims in the hospital, the u.s. centers for disease control and prevention said thursday. nearly 400 people have become ill in the outbreak that ...
www.foxnews.com

Georgia, 41 Other States In Salmonella Outbreak - Access North Ga
georgia reports that five people have taken ill in five different counties. atlanta - a nationwide salmonella outbreak that has struck 42 states has put about one in five of its victims in the hospital, the u.s. centers for disease control and ...
www.accessnorthga.com

Novabay Issued Key Composition Of Matter Patent For Aganocide(r ... - Streetinsider.com
emeryville, calif.--(business wire)-- novabay pharmaceuticals, inc. (amex: nby, www.novabaypharma.com ) reports that the united states patent and trademark office has approved the issuance of u.s. patent no. 7,462,361 to novabay for novel aganocide ...
www.streetinsider.com

Baby Selected To Be Free From Breast Cancer Gene Is Born - Daily Telegraph
she grew from an embryo screened to ensure it did not contain the faulty brca 1 gene, carried by 37,000 women in the uk, which passes the risk of breast cancer down generations. university college london said the the mother and her little girl were ...
www.telegraph.co.uk

Baby Selected To Be Free Of Cancer Gene - New Scientist
the first baby genetically selected to be free of a form of breast cancer - caused by a gene called brca1 - has been born in london. doctors said three generations of women in the baby girl's family had suffered from breast and ovarian cancer in ...
www.newscientist.com

Britain's First Cancer-free Designer Baby Born After Being Screened ... - Daily Mail
the first british baby genetically selected to be free of breast cancer to avoid developing the disease in later life has been born. university college hospital in london, which announced the birth this morning, said the baby girl was 'doing very ...
www.dailymail.co.uk